title: Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia.
abstract: This study presents an analysis of the factors associated with HTLV-I seroprevalence in the endemic area of Tumaco, Colombia. During June to August 1988, 1,077 individuals were selected at random from a population of 45,594. The overall prevalence rate of HTLV-I antibodies was 2.8%. Among females prevalence was significantly higher (p less than 0.02) than among males. Rates increased substantially with age. HTLV-I prevalence among individuals with history of use of intravenous medications was significantly higher (p less than 0.001) than in those without such history. Logistic regression analysis included age in years, indicators for male gender, and for i.v. injections, and their interactions. Age was very strongly associated to HTLV-I infection among females. At early ages prevalence was not different between sexes, but females presented a significantly higher rate than males after age 42. History of i.v. administered medications was very strongly associated in the univariate analysis and, although significance was borderline in the multivariate analysis, it had the effect of doubling the odds of HTLV-I infection.
authors.affiliation: Department of Immunology and Infectious Diseases, Johns Hopkins University, School of Hygiene & Public Health, Baltimore, MD.
authors.forename: J M
authors.initials: JM
authors.lastname: Trujillo
authors.forename: M
authors.initials: M
authors.lastname: Concha
authors.forename: A
authors.initials: A
authors.lastname: Muñoz
authors.forename: G
authors.initials: G
authors.lastname: Bergonzoli
authors.forename: C
authors.initials: C
authors.lastname: Mora
authors.forename: I
authors.initials: I
authors.lastname: Borrero
authors.forename: C J
authors.initials: CJ
authors.lastname: Gibbs
authors.forename: C
authors.initials: C
authors.lastname: Arango
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003105:Colombia / Q000453:epidemiology; D005260:Female; D015490:HTLV-I Infections / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011897:Random Allocation; D012044:Regression Analysis; D012307:Risk Factors; D016036:Seroepidemiologic Studies
chemical_list: D000914:Antibodies, Viral